Log on / register
Feedback | Support | My details
Inflammation and breast cancer. Cyclooxygenase/prostaglandin signaling and breast cancer.
Howe LR
Breast Cancer Res 2007, 9:210
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

PubMed Central articles that cite the above article:

1.
Combination chemoprevention of HER2/neu-induced breast cancer using a cyclooxygenase-2 inhibitor and a retinoid X receptor-selective retinoid.
Brown PH, Subbaramaiah K, Salmon AP, Baker R, Newman RA, Yang P, Zhou XK, Bissonnette RP, Dannenberg AJ, Howe LR
Cancer Prev Res (Phila Pa) 2008 Aug, 1:208-14
 [PubMed Central] [PubMed] [Related articles]
2.
Modulation of breast cancer risk by nonsteroidal anti-inflammatory drugs.
Howe LR, Lippman SM
J Natl Cancer Inst 2008 Oct 15, 100:1420-3
 [PubMed Central] [PubMed] [Related articles]
3.
Cox-2 inactivates Smad signaling and enhances EMT stimulated by TGF-beta through a PGE2-dependent mechanisms.
Neil JR, Johnson KM, Nemenoff RA, Schiemann WP
Carcinogenesis 2008 Nov, 29:2227-35
 [PubMed Central] [PubMed] [Related articles]

This article is also cited by 3 articles in BioMed Central


You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.